Clinical Trial Update: Study to Evaluate the Safety of Twice Daily Oral Carvedilol [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety of twice-daily carvedilol in congestive heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Coreg (carvedilol)

Snippet

Sponsor: Shaddy, Robert, M.D. | Conditions: Congestive Heart Failure | Phase 3 | Status: COMPLETED